Abstract
One quarter of the global population is estimated to have nonalcoholic fatty liver disease (NAFLD). The incidence of nonalcoholic steatohepatitis (NASH) is projected to increase by up to 56% in the next 10 years. NAFLD is already the fastest growing cause of hepatocellular carcinoma (HCC) in the USA, France and the UK. Globally, the prevalence of NAFLD-related HCC is likely to increase concomitantly with the growing obesity epidemic. The estimated annual incidence of HCC ranges from 0.5% to 2.6% among patients with NASH cirrhosis. The incidence of HCC among patients with non-cirrhotic NAFLD is lower, approximately 0.1 to 1.3 per 1,000 patient-years. Although the incidence of NAFLD-related HCC is lower than that of HCC of other aetiologies such as hepatitis C, more people have NAFLD than other liver diseases. Urgent measures that increase global awareness and tackle the metabolic risk factors are necessary to reduce the impending burden of NAFLD-related HCC. Emerging evidence indicates that reduced immune surveillance, increased gut inflammation and gut dysbiosis are potential key steps in tumorigenesis. In this Review, we discuss the global epidemiology, projections and risk factors for NAFLD-related HCC, and propose preventive strategies to tackle this growing problem.
Keywords
MedicineNonalcoholic fatty liver diseaseHepatocellular carcinomaInternal medicineEpidemiologyIncidence (geometry)CirrhosisGastroenterologyLiver cancerFatty liverDisease
MeSH Terms
CarcinomaHepatocellularDisease ProgressionForecastingGlobal HealthHumansIncidenceLiver NeoplasmsNon-alcoholic Fatty Liver DiseasePrevalencePrognosisRisk Factors
Affiliated Institutions
Related Publications
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. We estimated the global prevalence, incidence, progression, and outcomes of NAFLD and nonal...
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
Aliment Pharmacol Ther 2011; 34: 274–285 Summary Background Non‐alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence co...
Nonalcoholic Steatohepatitis
Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as a common liver disorder that represents the hepatic manifestation of the metabolic syndrome, a varia...
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
These recommendations are based on the following: (1) a formal review and analysis of the recently published world literature on the topic [Medline search up to June 2011]; (2) ...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 18
- Issue
- 4
- Pages
- 223-238
- Citations
- 1677
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1677
OpenAlex
84
Influential
Cite This
Daniel Q. Huang,
Hashem B. El‐Serag,
Rohit Loomba
(2020).
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
Nature Reviews Gastroenterology & Hepatology
, 18
(4)
, 223-238.
https://doi.org/10.1038/s41575-020-00381-6
Identifiers
- DOI
- 10.1038/s41575-020-00381-6
- PMID
- 33349658
- PMCID
- PMC8016738